| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2025-12-28 | FY 2023
FILED 2024-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $2.90B | $2.84B | $2.95B |
| YoY Revenue Growth % | +1.9% | -3.4% | — |
| Gross Profit | $1.31B | $1.37B | — |
| Gross Margin % | 45.4% | 48.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $143.9M | $254.7M | $323.4M |
| Operating Margin % | 5.0% | 9.0% | 11.0% |
| Net Income (GAAP) | $91.8M | $185.5M | $232.5M |
| EBITDA (Normalized) | $186.9M | $299.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $122.3M | $298.8M | $529.1M |
| Capital Expenditures (CapEx) | $53.7M | $56.2M | — |
| Free Cash Flow (FCF) | $68.6M | $242.6M | $529.1M |
| FCF Margin % | 2.4% | 8.5% | 18.0% |
| Return on Invested Capital (ROIC %) | 11.3% | 21.4% | — |
| Cash & Short-Term Equivalents | $487.1M | $412.9M | — |
| Total Debt (Short + Long Term) | $567.2M | $498.1M | — |
| Total Stockholders' Equity | $925.0M | $854.6M | — |